help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosner, D.
Right arrow Articles by Bennett, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosner, D.
Right arrow Articles by Bennett, M.
(American Journal of Pathology. 2006;168:2054-2063.)
© 2006 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2006.050473

Interferon-{gamma} Induces Fas Trafficking and Sensitization to Apoptosis in Vascular Smooth Muscle Cells via a PI3K- and Akt-Dependent Mechanism

Dalya Rosner*, Victoria Stoneman*, Trevor Littlewood*, Nicola McCarthy*, Nichola Figg*, Yinong Wang{dagger}, George Tellides{dagger} and Martin Bennett*

From the Division of Cardiovascular Medicine,* University of Cambridge Clinical School of Medicine Addenbrooke’s Centre for Clinical Investigation, Addenbrooke’s Hospital, Cambridge, United Kingdom; and the Interdepartmental Program in Vascular Biology and Transplantation,{dagger} Boyer Center for Molecular Medicine, Department of Surgery, Yale University School of Medicine, New Haven, Connecticut

Vascular smooth muscle cell (VSMC) apoptosis occurs in advanced atherosclerotic plaques where it may contribute to plaque instability. VSMCs express the death receptor Fas but are relatively resistant to Fas-induced apoptosis due in part to the intracellular sequestration of Fas. Although inflammatory cytokines such as interferon (IFN)-{gamma} present in plaques can prime VSMCs to FasL-induced death, the mechanism of this effect is unclear. We examined Fas expression and FasL-induced apoptosis in human VSMCs in response to IFN-{gamma}. IFN-{gamma} induced Fas trafficking to the cell surface within 24 hours, an effect that required Jak2/Stat1 activity. IFN-{gamma} also stimulated Akt activity, and both Fas trafficking and Stat1 activation were inhibited by blocking PI3K, Akt, or Jak-2. IFN-{gamma} increased Fas-induced apoptosis in vitro by 46 ± 8% (mean ± SEM, P = 0.04), an event that could be abrogated by inhibition of PI3K, Akt, or Jak-2. IFN-{gamma} also increased Fas-induced apoptosis in vivo 7.5- to 15-fold (P < 0.05) in human arteries transplanted into immunodeficient mice, accompanied by increased Fas and phospho-Ser727-Stat1. We conclude that IFN-{gamma} primes VSMCs to Fas-induced apoptosis, in part by relocation of Fas to the cell surface, a process that involves PI3K, Akt, and Jak-2/Stat1. IFN-{gamma} present in plaques may co-operate with FasL to induce VSMC apoptosis in atherosclerosis.





This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
D. Allard, N. Figg, M. R. Bennett, and T. D. Littlewood
Akt Regulates the Survival of Vascular Smooth Muscle Cells via Inhibition of FoxO3a and GSK3
J. Biol. Chem., July 11, 2008; 283(28): 19739 - 19747.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J.-W. Park, H. P. Kim, S.-J. Lee, X. Wang, Y. Wang, E. Ifedigbo, S. C. Watkins, M. Ohba, S. W. Ryter, Y. M. Vyas, et al.
Protein Kinase C{alpha} and {zeta} Differentially Regulate Death-Inducing Signaling Complex Formation in Cigarette Smoke Extract-Induced Apoptosis
J. Immunol., April 1, 2008; 180(7): 4668 - 4678.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Bai, U. Ahmad, Y. Wang, J. H. Li, J. C. Choy, R. W. Kim, N. Kirkiles-Smith, S. E. Maher, J. G. Karras, C. F. Bennett, et al.
Interferon-{gamma} Induces X-linked Inhibitor of Apoptosis-associated Factor-1 and Noxa Expression and Potentiates Human Vascular Smooth Muscle Cell Apoptosis by STAT3 Activation
J. Biol. Chem., March 14, 2008; 283(11): 6832 - 6842.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
N. Yang, M. Luo, R. Li, Y. Huang, R. Zhang, Q. Wu, F. Wang, Y. Li, and X. Yu
Blockage of JAK/STAT signalling attenuates renal ischaemia-reperfusion injury in rats
Nephrol. Dial. Transplant., January 1, 2008; 23(1): 91 - 100.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Wang, Y. Bai, L. Qin, P. Zhang, T. Yi, S. A. Teesdale, L. Zhao, J. S. Pober, and G. Tellides
Interferon-{gamma} Induces Human Vascular Smooth Muscle Cell Proliferation and Intimal Expansion by Phosphatidylinositol 3-Kinase Dependent Mammalian Target of Rapamycin Raptor Complex 1 Activation
Circ. Res., September 14, 2007; 101(6): 560 - 569.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Guo, T. Zhu, Z.-X. J. Xiao, and C.-Y. Chen
Modulation of Intracellular Signaling Pathways to Induce Apoptosis in Prostate Cancer Cells
J. Biol. Chem., August 17, 2007; 282(33): 24364 - 24372.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
I. Gotsman and A. H. Lichtman
Targeting Interferon-{gamma} to Treat Atherosclerosis
Circ. Res., August 17, 2007; 101(4): 333 - 334.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
Y. S. Chatzizisis, A. U. Coskun, M. Jonas, E. R. Edelman, C. L. Feldman, and P. H. Stone
Role of Endothelial Shear Stress in the Natural History of Coronary Atherosclerosis and Vascular Remodeling: Molecular, Cellular, and Vascular Behavior
J. Am. Coll. Cardiol., June 26, 2007; 49(25): 2379 - 2393.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. J. Keogh, L. K. Harris, A. Freeman, P. N. Baker, J. D. Aplin, G. StJ. Whitley, and J. E. Cartwright
Fetal-Derived Trophoblast Use the Apoptotic Cytokine Tumor Necrosis Factor-{alpha}-Related Apoptosis-Inducing Ligand to Induce Smooth Muscle Cell Death
Circ. Res., March 30, 2007; 100(6): 834 - 841.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Tellides and J. S. Pober
Interferon-{gamma} Axis in Graft Arteriosclerosis
Circ. Res., March 16, 2007; 100(5): 622 - 632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Society for Investigative Pathology.